Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:phosphate_binder
|
| gptkbp:activeIngredient |
gptkb:sucroferric_oxyhydroxide
|
| gptkbp:approvedBy |
gptkb:FDA
2013 |
| gptkbp:ATCCode |
gptkb:V03AE05
|
| gptkbp:form |
chewable tablet
|
| gptkbp:manufacturer |
gptkb:Fresenius_Medical_Care
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea discolored feces |
| gptkbp:usedFor |
hyperphosphatemia in chronic kidney disease
|
| gptkbp:bfsParent |
gptkb:Vifor_Pharma
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Velphoro
|